Published in Hum Genet on December 01, 1992
Target gene analyses of 39 amelogenesis imperfecta kindreds. Eur J Oral Sci (2011) 1.97
Amelogenesis imperfecta. Orphanet J Rare Dis (2007) 1.85
The molecular etiologies and associated phenotypes of amelogenesis imperfecta. Am J Med Genet A (2006) 1.79
Molecular evolution of amelogenin in mammals. J Mol Evol (2005) 1.07
Binding of amelogenin to MMP-9 and their co-expression in developing mouse teeth. J Mol Histol (2012) 0.92
Exclusion of known gene for enamel development in two Brazilian families with amelogenesis imperfecta. Head Face Med (2007) 0.91
The influence of Leucine-rich amelogenin peptide on MSC fate by inducing Wnt10b expression. Biomaterials (2011) 0.89
Transcription factor FoxO1 is essential for enamel biomineralization. PLoS One (2012) 0.78
Phenotype-genotype correlations in mouse models of amelogenesis imperfecta caused by Amelx and Enam mutations. Cells Tissues Organs (2012) 0.77
Novel genetic linkage of rat Sp6 mutation to Amelogenesis imperfecta. Orphanet J Rare Dis (2012) 0.76
Enamel ribbons, surface nodules, and octacalcium phosphate in C57BL/6 Amelx(-/-) mice and Amelx(+/-) lyonization. Mol Genet Genomic Med (2016) 0.75
Preparative SDS PAGE as an Alternative to His-Tag Purification of Recombinant Amelogenin. Front Physiol (2017) 0.75
Role of MIZ-1 in AMELX gene expression. Biochem Biophys Rep (2016) 0.75
Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell (1990) 7.12
On a Back Cross in Mice Involving Three Allelomorphic Pairs of Characters. Genetics (1918) 6.12
Situs inversus and embryonic ciliary morphogenesis defects in mouse mutants lacking the KIF3A subunit of kinesin-II. Proc Natl Acad Sci U S A (1999) 4.11
Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol Cell Biol (2000) 3.93
Actin-like filaments in the cleavage furrow of newt egg. Exp Cell Res (1971) 3.53
Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet (1999) 3.01
Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science (1988) 2.82
Rapid gas-liquid chromatographic estimation of antipyrine in plasma. J Pharm Pharmacol (1973) 2.31
Hardy-Weinberg quality control. Ann Hum Genet (1999) 2.22
Genetic linkage between Becker muscular dystrophy and a polymorphic DNA sequence on the short arm of the X chromosome. J Med Genet (1983) 2.16
DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study. Neurology (2003) 2.14
A randomised trial of calcium alginate swabs to control blood loss in 3-5-year-old children. Br Dent J (1998) 2.09
Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy. Lancet (1987) 2.08
A new method for autozygosity mapping using single nucleotide polymorphisms (SNPs) and EXCLUDEAR. J Med Genet (2004) 2.02
The complex nature of constitutional de novo apparently balanced translocations in patients presenting with abnormal phenotypes. J Med Genet (2005) 1.94
A pseudoautosomal gene in man. Science (1986) 1.94
Fractional utilization of the aerobic capacity during distance running. Med Sci Sports (1973) 1.93
Randomized trial of a specialist genetic assessment service for familial breast cancer. J Natl Cancer Inst (2000) 1.92
A third novel locus for primary autosomal recessive microcephaly maps to chromosome 9q34. Am J Hum Genet (2000) 1.91
Mutations in WNT7A cause a range of limb malformations, including Fuhrmann syndrome and Al-Awadi/Raas-Rothschild/Schinzel phocomelia syndrome. Am J Hum Genet (2006) 1.85
Biochemical-physiological correlations in studies of the gamma-aminobutyric acid system. Brain Res (1968) 1.80
Analysis of result variability from high-density oligonucleotide arrays comparing same-species and cross-species hybridizations. Biotechniques (2002) 1.80
Three distinct DNA ligases in mammalian cells. J Biol Chem (1991) 1.79
A carbon-phosphorus bond in nature. Science (1969) 1.77
Localisation of the Becker muscular dystrophy gene on the short arm of the X chromosome by linkage to cloned DNA sequences. Hum Genet (1984) 1.74
GABA neurons are the major cell type of the nucleus reticularis thalami. Brain Res (1980) 1.72
Development of antibodies to unprotected glycosylation sites on recombinant human GM-CSF. Lancet (1990) 1.71
Cloning of Drosophila choline acetyltransferase cDNA. Proc Natl Acad Sci U S A (1986) 1.65
Physical mapping of new DNA probes near the fragile X mutation (FRAXA) by using a panel of cell lines. Am J Hum Genet (1990) 1.60
Focal infections of the central nervous system due to Propionibacterium acnes. J Infect (1989) 1.55
CRASH trial is based on problematic meta-analysis. BMJ (1999) 1.55
The phenotypic manifestations of interstitial duplications of proximal 15q with special reference to the autistic spectrum disorders. Am J Med Genet (2001) 1.54
Cree encephalitis is allelic with Aicardi-Goutiéres syndrome: implications for the pathogenesis of disorders of interferon alpha metabolism. J Med Genet (2003) 1.53
Becker muscular dystrophy: correlation of deletion type with clinical severity. J Med Genet (1990) 1.50
The fine structural localization of glutamate decarboxylase in synaptic terminals of rodent cerebellum. Brain Res (1974) 1.48
Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc Natl Acad Sci U S A (1992) 1.46
A fifth locus for primary autosomal recessive microcephaly maps to chromosome 1q31. Am J Hum Genet (2000) 1.45
The survival of Class V restorations in general dental practice: part 3, five-year survival. Br Dent J (2012) 1.42
Cyclin D3 compensates for loss of cyclin D2 in mouse B-lymphocytes activated via the antigen receptor and CD40. J Biol Chem (2000) 1.39
The survival of Class V restorations in general dental practice. Part 2, early failure. Br Dent J (2011) 1.39
A helping hand? Br Dent J (1994) 1.37
Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Br J Cancer (1992) 1.36
Genetic linkage relationships of seven DNA probes with Duchenne and Becker muscular dystrophy. Hum Genet (1985) 1.33
Purification and characterization of glutamate decarboxylase from mouse brain. J Biol Chem (1973) 1.32
X-linked hypohidrotic ectodermal dysplasia: DNA probe linkage analysis and gene localization. Hum Genet (1987) 1.31
Mapping genetic markers on human chromosome 19 using subchromosomal fragments in somatic cell hybrids. Cytogenet Cell Genet (1986) 1.29
Elevation of gamma-aminobutyric acid in brain with amino-oxyacetic acid and susceptibility to convulsive seizures in mice: a quantitative re-evaluation. Biochem Pharmacol (1966) 1.29
Clinical findings in 33 subjects with large supernumerary marker(15) chromosomes and 3 subjects with triplication of 15q11-q13. Am J Med Genet A (2006) 1.28
Electron microscopic study of methylcholanthrene-induced epidermal carcinogenesis in mice: mitochondrial dense bodies and intracisternal A-particles. Cancer Res (1970) 1.28
The experimental herbicide CGA 325'615 inhibits synthesis of crystalline cellulose and causes accumulation of non-crystalline beta-1,4-glucan associated with CesA protein. Plant Physiol (2001) 1.27
Karak syndrome: a novel degenerative disorder of the basal ganglia and cerebellum. J Med Genet (2003) 1.27
A NEW MUTATION IN THE HOUSE MOUSE (MUS MUSCULUS). Science (1931) 1.26
The glutamine 27 beta2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families. J Allergy Clin Immunol (1997) 1.25
Precision in estimating gestational age and its influence on sensitivity of alphafetoprotein screening. Br Med J (1979) 1.24
Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways. J Immunol (2001) 1.24
Effects of naloxone in senile dementia: a double-blind trial. N Engl J Med (1983) 1.23
The importance of seeking ALMS1 mutations in infants with dilated cardiomyopathy. J Med Genet (2005) 1.23
Distribution of reversing factor in reticulocyte lysates during active protein synthesis and on inhibition by heme deprivation or double-stranded RNA. Proc Natl Acad Sci U S A (1984) 1.23
Tumor necrosis factor-alpha stimulates the maturation of sterol regulatory element binding protein-1 in human hepatocytes through the action of neutral sphingomyelinase. J Biol Chem (1998) 1.22
Molecular analysis of 20 patients with 2q37.3 monosomy: definition of minimum deletion intervals for key phenotypes. J Med Genet (2004) 1.22
X-linked hypohidrotic ectodermal dysplasia: localization within the region Xq11-21.1 by linkage analysis and implications for carrier detection and prenatal diagnosis. Am J Hum Genet (1988) 1.21
The origin, distribution and synaptic relationships of substance P axons in rat spinal cord. J Comp Neurol (1979) 1.21
A novel locus for autosomal recessive primary microcephaly (MCPH6) maps to 13q12.2. J Med Genet (2003) 1.21
Effects of protease inhibitors on growth of hamster tumor cells in culture. Cancer Res (1972) 1.20
Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. Proc Natl Acad Sci U S A (1997) 1.19
The cytoarchitecture of GABAergic neurons in rat spinal cord. Brain Res (1982) 1.15
The gamma-aminobutyric acid system in rabbit retina. Brain Res (1968) 1.15
Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features. N Engl J Med (1991) 1.13
GABAergic terminals are presynaptic to primary afferent terminals in the substantia gelatinosa of the rat spinal cord. Brain Res (1978) 1.13
Amnestic effects in mice of four synthetic peptides homologous to amyloid beta protein from patients with Alzheimer disease. Proc Natl Acad Sci U S A (1991) 1.12
New diarylmethylpiperazines as potent and selective nonpeptidic delta opioid receptor agonists with increased In vitro metabolic stability. J Med Chem (2000) 1.11
Immunocytochemical localization of glutamate decarboxylase in rat substantia nigra. Brain Res (1976) 1.11
Cauda equina syndrome associated with multiple lumbar arachnoid cysts in ankylosing spondylitis: improvement following surgical therapy. J Neurol Neurosurg Psychiatry (1990) 1.10
BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression. J Biol Chem (2001) 1.10
Pregnenolone sulfate enhances post-training memory processes when injected in very low doses into limbic system structures: the amygdala is by far the most sensitive. Proc Natl Acad Sci U S A (1995) 1.10
The A-Myb transcription factor is a marker of centroblasts in vivo. J Immunol (1998) 1.10
Congenital malformations of the diaphragm: findings of the West Midlands Congenital Anomaly Register 1995 to 2000. Prenat Diagn (2004) 1.10
Factors affecting presentation and delay in patients with testicular cancer: results of a qualitative study. Psychooncology (1999) 1.09
Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry (1999) 1.08
Immunocytochemical localization of glutamate decarboxylase in rat spinal cord. J Comp Neurol (1975) 1.08
The 60 S ribosomal subunit as a carrier of eukaryotic initiation factor 2 and the site of reversing factor activity during protein synthesis. J Biol Chem (1985) 1.08
Molecular and fluorescence in situ hybridization characterization of the breakpoints in 46 large supernumerary marker 15 chromosomes reveals an unexpected level of complexity. Am J Hum Genet (2003) 1.08
PCR phenotyping of cytokines, growth factors and their receptors and bone matrix proteins in human osteoblast-like cell lines. Bone (1996) 1.07
Phenotypic evidence for a common pathogenesis in X-linked deafness pedigrees and in Xq13-q21 deletion related deafness. Am J Med Genet (1992) 1.07
A study of females with deletions of the short arm of the X chromosome. Hum Genet (1998) 1.07
Intragenic deletions in 164 boys with Duchenne muscular dystrophy (DMD) studied with dystrophin cDNA. Clin Genet (1990) 1.06
Hypodontia, ectodermal dysplasia and sweat pore count. Br Dent J (1985) 1.06
Lck is a key target of imatinib and dasatinib in T-cell activation. Leukemia (2010) 1.04
A new locus for autosomal dominant familial exudative vitreoretinopathy maps to chromosome 11p12-13. Am J Hum Genet (2001) 1.04
Duchenne muscular dystrophy with adrenal insufficiency and glycerol kinase deficiency: high resolution cytogenetic analysis with molecular, biochemical, and clinical studies. J Med Genet (1986) 1.04
Control of blood gas measurements in intensive-care units. Lancet (1991) 1.04
The fine structural localization of glutamate decarboxylase in developing axonal processes and presynaptic terminals of rodent cerebellum. Brain Res (1975) 1.04
Inhibitory, GABAergic nerve terminals decrease at sites of focal epilepsy. Science (1979) 1.04
Novel "restoration of function" mutagenesis strategy to identify amino acids of the delta-opioid receptor involved in ligand binding. J Biol Chem (1997) 1.04
Localisation of the gene for Emery-Dreifuss muscular dystrophy to the distal long arm of the X chromosome. J Med Genet (1986) 1.03
BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells. Oncogene (2001) 1.03
Aicardi-Goutières syndrome displays genetic heterogeneity with one locus (AGS1) on chromosome 3p21. Am J Hum Genet (2000) 1.03
The B-cell and neuronal forms of the octamer-binding protein Oct-2 differ in DNA-binding specificity and functional activity. Mol Cell Biol (1991) 1.02
Molecular deletion analysis in Duchenne muscular dystrophy. J Med Genet (1986) 1.02
Gamma-aminobutyric acid and nervous system function--a perspective. Biochem Pharmacol (1974) 1.02